Cargando…

Comparing COVID-19 and Influenza Presentation and Trajectory

Background: COVID-19 is a newly recognized illness with a predominantly respiratory presentation. It is important to characterize the differences in disease presentation and trajectory between COVID-19 patients and other patients with common respiratory illnesses. These differences can enhance knowl...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiner Benaim, Anat, Sobel, Jonathan A., Almog, Ronit, Lugassy, Snir, Ben Shabbat, Tsviel, Johnson, Alistair, Eytan, Danny, Behar, Joachim A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160103/
https://www.ncbi.nlm.nih.gov/pubmed/34055833
http://dx.doi.org/10.3389/fmed.2021.656405
_version_ 1783700213148418048
author Reiner Benaim, Anat
Sobel, Jonathan A.
Almog, Ronit
Lugassy, Snir
Ben Shabbat, Tsviel
Johnson, Alistair
Eytan, Danny
Behar, Joachim A.
author_facet Reiner Benaim, Anat
Sobel, Jonathan A.
Almog, Ronit
Lugassy, Snir
Ben Shabbat, Tsviel
Johnson, Alistair
Eytan, Danny
Behar, Joachim A.
author_sort Reiner Benaim, Anat
collection PubMed
description Background: COVID-19 is a newly recognized illness with a predominantly respiratory presentation. It is important to characterize the differences in disease presentation and trajectory between COVID-19 patients and other patients with common respiratory illnesses. These differences can enhance knowledge of pathogenesis and help in guiding treatment. Methods: Data from electronic medical records were obtained from individuals admitted with respiratory illnesses to Rambam Health Care Campus, Haifa, Israel, between October 1st, 2014 and October 1st, 2020. Four groups of patients were defined: COVID-19 (693), influenza (1,612), severe acute respiratory infection (SARI) (2,292), and Others (4,054). The variable analyzed include demographics (7), vital signs (8), lab tests (38), and comorbidities (15) from a total of 8,651 hospitalized adult patients. Statistical analysis was performed on biomarkers measured at admission and for their disease trajectory in the first 48 h of hospitalization, and on comorobidity prevalence. Results: COVID-19 patients were overall younger in age and had higher body mass index, compared to influenza and SARI. Comorbidity burden was lower in the COVID-19 group compared to influenza and SARI. Severely- and moderately-ill COVID-19 patients older than 65 years of age suffered higher rate of in-hospital mortality compared to hospitalized influenza patients. At admission, white blood cells and neutrophils were lower among COVID-19 patients compared to influenza and SARI patients, while pulse rate and lymphoctye percentage were higher. Trajectories of variables during the first 2 days of hospitalization revealed that white blood count, neutrophils percentage and glucose in blood increased among COVID-19 patients, while decreasing among other patients. Conclusions: The intrinsic virulence of COVID-19 appeared higher than influenza. In addition, several critical functions, such as immune response, coagulation, heart and respiratory function, and metabolism were uniquely affected by COVID-19.
format Online
Article
Text
id pubmed-8160103
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81601032021-05-29 Comparing COVID-19 and Influenza Presentation and Trajectory Reiner Benaim, Anat Sobel, Jonathan A. Almog, Ronit Lugassy, Snir Ben Shabbat, Tsviel Johnson, Alistair Eytan, Danny Behar, Joachim A. Front Med (Lausanne) Medicine Background: COVID-19 is a newly recognized illness with a predominantly respiratory presentation. It is important to characterize the differences in disease presentation and trajectory between COVID-19 patients and other patients with common respiratory illnesses. These differences can enhance knowledge of pathogenesis and help in guiding treatment. Methods: Data from electronic medical records were obtained from individuals admitted with respiratory illnesses to Rambam Health Care Campus, Haifa, Israel, between October 1st, 2014 and October 1st, 2020. Four groups of patients were defined: COVID-19 (693), influenza (1,612), severe acute respiratory infection (SARI) (2,292), and Others (4,054). The variable analyzed include demographics (7), vital signs (8), lab tests (38), and comorbidities (15) from a total of 8,651 hospitalized adult patients. Statistical analysis was performed on biomarkers measured at admission and for their disease trajectory in the first 48 h of hospitalization, and on comorobidity prevalence. Results: COVID-19 patients were overall younger in age and had higher body mass index, compared to influenza and SARI. Comorbidity burden was lower in the COVID-19 group compared to influenza and SARI. Severely- and moderately-ill COVID-19 patients older than 65 years of age suffered higher rate of in-hospital mortality compared to hospitalized influenza patients. At admission, white blood cells and neutrophils were lower among COVID-19 patients compared to influenza and SARI patients, while pulse rate and lymphoctye percentage were higher. Trajectories of variables during the first 2 days of hospitalization revealed that white blood count, neutrophils percentage and glucose in blood increased among COVID-19 patients, while decreasing among other patients. Conclusions: The intrinsic virulence of COVID-19 appeared higher than influenza. In addition, several critical functions, such as immune response, coagulation, heart and respiratory function, and metabolism were uniquely affected by COVID-19. Frontiers Media S.A. 2021-05-14 /pmc/articles/PMC8160103/ /pubmed/34055833 http://dx.doi.org/10.3389/fmed.2021.656405 Text en Copyright © 2021 Reiner Benaim, Sobel, Almog, Lugassy, Ben Shabbat, Johnson, Eytan and Behar. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Reiner Benaim, Anat
Sobel, Jonathan A.
Almog, Ronit
Lugassy, Snir
Ben Shabbat, Tsviel
Johnson, Alistair
Eytan, Danny
Behar, Joachim A.
Comparing COVID-19 and Influenza Presentation and Trajectory
title Comparing COVID-19 and Influenza Presentation and Trajectory
title_full Comparing COVID-19 and Influenza Presentation and Trajectory
title_fullStr Comparing COVID-19 and Influenza Presentation and Trajectory
title_full_unstemmed Comparing COVID-19 and Influenza Presentation and Trajectory
title_short Comparing COVID-19 and Influenza Presentation and Trajectory
title_sort comparing covid-19 and influenza presentation and trajectory
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160103/
https://www.ncbi.nlm.nih.gov/pubmed/34055833
http://dx.doi.org/10.3389/fmed.2021.656405
work_keys_str_mv AT reinerbenaimanat comparingcovid19andinfluenzapresentationandtrajectory
AT sobeljonathana comparingcovid19andinfluenzapresentationandtrajectory
AT almogronit comparingcovid19andinfluenzapresentationandtrajectory
AT lugassysnir comparingcovid19andinfluenzapresentationandtrajectory
AT benshabbattsviel comparingcovid19andinfluenzapresentationandtrajectory
AT johnsonalistair comparingcovid19andinfluenzapresentationandtrajectory
AT eytandanny comparingcovid19andinfluenzapresentationandtrajectory
AT beharjoachima comparingcovid19andinfluenzapresentationandtrajectory